Search

Business & Regulation Trends & Forecasts

04/24/2025 | 4 min read

Our latest news roundup reports on Roche’s US investment, a lawsuit against Vertex Pharmaceuticals, and more.

Business & Regulation Trends & Forecasts

04/23/2025 | Rob Coker | 2 min read

EMA reflection paper considers elimination of routine comparative efficacy studies for biosimilars.

Discovery & Development Drug Discovery

04/23/2025 | Stephanie Vine | 6 min read

We speak to the 2025 winner of Novo Nordisk and Pioneer Group’s Golden Ticket program.

Manufacture Facilities

04/22/2025 | Stephanie Vine | 2 min read

FUJIFILM Diosynth to manufacture biologics for Regeneron at new facility in Holly Springs, North Carolina.

Manufacture Advanced Medicine

04/22/2025 | Efrain Guzman | 3 min read

Overcoming the limitations of the triple plasmid transient transfection method for AAV manufacturing.

Discovery & Development Dosage Forms

04/21/2025 | Stephanie Vine | 5 min read

We speak with Colorcon CEO Simon Tasker about the importance of the patient experience when it comes to medicines.

Business & Regulation Standards & Regulation

04/21/2025 | Rob Coker | 2 min read

Trump signs executive order on lowering drug prices and amends Medicare price negotiation for small molecule drugs.

Business & Regulation Profession

04/17/2025 | Stephanie Vine | 5 min read

Simon Tasker joined Colorcon as a bench chemist – and never left. Today, he’s the company’s CEO. Here’s how his career unfolded.

Business & Regulation Standards & Regulation

04/17/2025 | Rob Coker | 3 min read

The political situation in the US and its impact on science and medicine is changing rapidly. Here’s a quick look at the latest developments.

Discovery & Development Drug Discovery

04/16/2025 | 4 min read

Discussing the development of trends, treatments, and talent in gene therapy with NewBiologix CEO Igor Fisch.